Sat.Mar 13, 2021 - Fri.Mar 19, 2021

article thumbnail

IBM-led group wins German contract for digital vaccine passport

pharmaphorum

Germany has awarded a tender to a consortium led by IBM to develop a secure app that will provide a digital version of the country’s paper vaccine certificates. The €2.7 million ($3.2 million) contract covers the app and a backend system to allow for integration with IT systems operating in medical practices and vaccination centres, according to details published in the Official Journal of the EU.

Vaccines 144
article thumbnail

Saama, Oracle partner on integrated clinical trial technology

Outsourcing Pharma

Saamaâs range of Smart applications will be integrated with the Oracle Health Sciences Clinical One platform to help users accelerate drug development.

105
105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AZ’s vaccine safety review shows ‘no evidence’ of an increased risk of blood clots

Pharma Times

Review included available safety data from over 17 million people vaccinated in the EU and UK with COVID-19 jab

article thumbnail

March 2021 Reflections

That Frugal Pharmacist

Time for another life/blog/business update! I admit, I’m all over the place. It’s part of what makes me so fun, right? I’m constantly trying new things. Do I want to be a pro-blogger? I ran my little experiment with a more professional approach for blogging via The Money Mix Insiders program. While I learned a … March 2021 Reflections Read More ».

52
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

The digital transformation of pharma’s physician engagement strategies

pharmaphorum

The exact shape of healthcare’s post-COVID ‘new normal’ is still being framed, but it is clear that some trends are already taking shape – and one of the key ones is digital transformation in pharma. The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians.

article thumbnail

Home health monitoring provides valuable patient insights: Current Health

Outsourcing Pharma

A leader from the trial solutions provider discusses how the COVID-19 pandemic has accelerated the already growing interest in remote patient monitoring.

85

More Trending

article thumbnail

Takeover of Spanish manufacturer STE Tecpharm, S. L. – Romaco expands processing business

Pharma Mirror

With the acquisition of the Spanish manufacturer STE Tecpharm, S. L., Romaco strengthens its position as a turnkey supplier of processing technologies. In particular, Tecpharm’s patented drum coaters will complement Romaco Innojet’s granulation and fluid bed technologies. On 18 March 2021, Romaco Holding GmbH announced the purchase of the Spanish manufacturer of processing technology STE Tecpharm, S.

52
article thumbnail

Regulators questioned integrity of Pfizer/BioNTech vaccine, leaked files show

pharmaphorum

European regulators questioned the integrity of early batches of Pfizer/BioNTech’s mRNA vaccine, although the matter was resolved before approval, according to information leaked online following a cyberattack. As it conducted its analysis of the vaccine in December, the European Medicines Agency’s systems were targeted by unknown hackers. Following this, more than 40 megabytes of classified information from the agency’s review were published on the dark web and several journalists, including th

Vaccines 138
article thumbnail

Sagent issues voluntary recall of phenylephrine hydrochloride vials

Outsourcing Pharma

The company is recalling 10 mg/mL vials of phenylephrine hydrochloride due to potential lack of sterility assurance in several lots of the product.

52
article thumbnail

GSK, Medicago launch late-stage trial of plant-derived COVID-19 vaccine

Pharma Times

Vaccine candidate has previously been granted FDA fast track designation

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

DarshanTalks: Marketing & Medical Affairs – March 9, 2021

Pharma Marketing Network

[link]. Marketing and medical affairs are often perceived as being separate. What happens when drug companies market their own products? Join Darshan Kulkarni as he talks with guest Dr. Stephen Towers about the intersection between marketing and medical affairs. Darshan and Stephen also discuss how medical affairs can inform marketing efforts. The post DarshanTalks: Marketing & Medical Affairs </br>– March 9, 2021 appeared first on Pharma Marketing Network.

52
article thumbnail

Could a smartphone cough app stop future pandemics?

pharmaphorum

A host of companies are looking at cough apps to detect the presence of COVID-19. But one company called Hyfe wants to take the idea a step further and use them to detect future pandemics, reports Richard Staines. . The pandemic has seen a plethora of digital tools emerge to help manage patients remotely, with the ubiquitous use of smartphone technology allowing medics to monitor patients’ vital signs without risky face-to-face contact.

122
122
article thumbnail

Creative clinical solutions come through in tough times: webinar

Outsourcing Pharma

With COVID-19 adding challenges to the already complex field, the April 6 Clinical Development Innovations webinar will share thoughtful solutions.

52
article thumbnail

Sanofi, Regeneron’s Libtayo improves survival in cervical cancer patients

Pharma Times

Phase III trial stopped early for positive result on overall survival

54
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

DZNE and Eisai Enter Into Research Collaboration Agreement Aiming for Novel Drug Discovery for Neurodegenerative Disorders

Pharma Mirror

Deutsches Zentrum fur Neurodegenerative Erkrankungen and Eisai Co., Ltd. today announced that both parties have entered into a research collaboration agreement aiming to create potential novel treatments for neurodegenerative disorders including Alzheimer’s disease (AD) which modulate immune competence in neurons and glia cells. DZNE is a world-leading interdisciplinary public research organization constituted with ten research sites in Germany that investigates methods for prevention, dia

article thumbnail

Protected: Using AI to make a big impact for emerging and mid-sized biopharma companies

pharmaphorum

This content is password protected. To view it please enter your password below: Password: The post Protected: Using AI to make a big impact for emerging and mid-sized biopharma companies appeared first on.

116
116
article thumbnail

Certara takes on TrialAssure data anonymization solution

Outsourcing Pharma

The biosimulation specialist will harness Certaraâs Anonymize software to help anonymize patient clinical data for its future research studies.

52
article thumbnail

UK and EU regulators reaffirm the safety of AZ/Oxford Uni’s COVID-19 vaccine

Pharma Times

MHRA and EMA conclude the vaccine's benefits continue to outweigh risks

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Cannabis Isn’t as Safe as You Think

Pharma Mirror

After over a half-century of lobbying, it seems that cannabis prohibition may finally come to an end at the federal level. For a lot of Americans, many of whom have seen their states legalize cannabis and marijuana products to varying degrees, this may seem like a natural course of events for the harmless but controversial plant. Except, cannabis isn’t entirely harmless.

52
article thumbnail

How COVID-19 has changed the role of pharma sales reps

pharmaphorum

The demise of the pharmaceutical sales representative has been greatly exaggerated over the years. But in the wake of the COVID-19 pandemic, there is an even greater need to re-examine the rep’s role. How can a field force evolve to deal with current challenges and be future-fit for the way we will be working in the post-pandemic world? The current restrictions on face-to-face meetings have exacerbated the trend of sales reps’ reduced access to healthcare customers.

article thumbnail

Gilead, Merck to team up on potential HIV combo treatment

Outsourcing Pharma

The two major pharmaceutical firms have agreed to jointly develop and commercialize treatment combinations of lenacapavir and islatravir in HIV patients.

52
article thumbnail

Cambridge Sleep Sciences and Parkinson’s Concierge to test sleep device in Parkinson’s disease

Pharma Times

SleepHub device to be assessed in people with Parkinson's associated sleep issues

52
article thumbnail

PCR Buffer: Polymerase Chain Reaction Mediator

Pharma Mirror

PCR buffer is a vital component of the Polymerase Chain Reaction, also called molecular photocopying. The reaction has helped scientists worldwide study DNA by providing its ample amount from minimal samples. It is almost impossible to carry on a PCR reaction without a buffer. But what is the main function of a PCR Buffer? How does it help in creating DNA copies?

article thumbnail

EMA review finds AZ COVID-19 vaccine “safe and effective”

pharmaphorum

An EMA advisory committee’s review of AstraZeneca’s COVID-19 has concluded that there is no increase in the overall risk of blood clots with this vaccine. The chair of the Pharmacovigilance Risk Assessment Committee (PRAC), Dr Sabine Straus, told a press briefing today that the vaccine “is safe and effective and its benefits continue to be far greater than its risks.”.

Vaccines 105
article thumbnail

GSK expands its clinical trial manufacturing capacity at dedicated CGT facility in UK

Outsourcing Pharma

Cell and Gene Therapy Catapult (CGT Catapult) says that GSK will leverage its Stevenage facility to perform GMP cell processing and accelerate its cell and gene therapy pipeline for clinical trials.

52
article thumbnail

Tamsulosin vs Finasteride: use, side effects & effectiveness

Druggist

Tamsulosin and finasteride are the two most common drugs licensed and used to manage benign prostatic hyperplasia (BPH). BPH is a condition characterised by an enlarged prostate, which may produce common symptoms such as increased urgency to urinate, poor urinary flow (difficult to start urination), increased urination at night (polyuria) and incomplete bladder emptying (individuals going back to the toilet few times because they feel they need to pee).

52
article thumbnail

Lilly’s donanemab slows decline in Phase II Alzheimer’s study

Pharma Times

Alzheimer’s Drug Discovery Foundation says results are ‘promising’

50
article thumbnail

Protein misfolding specialist Gain nets $40m from IPO

pharmaphorum

Gain Therapeutics has priced its initial public offering, raising more than $40 million for its computational drug discovery platform and pipeline of drugs for diseases associated with protein misfolding. . The shares began trading on the Nasdaq yesterday under the symbol ‘GANX’, closing at $11.20 and valuing the company at around $130 million. Bethesda, Maryland-headquartered Gain, which was originally formed in Switzerland, is focusing initial on lysosomal storage disorders (LSDs), a group of

103
103
article thumbnail

IQVIA announces growth in Orchestrated Customer Engagement solution

Outsourcing Pharma

The Orchestrated Customer Engagement Technology reportedly has been adopted by 140 life sciences companies (including top-10 pharma firms) in nearly 90.

52
article thumbnail

Bromocriptine Clinical Pearls

Med Ed 101

I don’t see bromocriptine used very often in clinical practice, but as a pharmacist, I feel the need to know every medication I come across. Here’s a list of my top bromocriptine clinical pearls! I think one of the most important things to recognize is that bromocriptine is a dopamine agonist. If you remember this […]. The post Bromocriptine Clinical Pearls appeared first on Med Ed 101.

40
article thumbnail

EU authorisation for XPhyto’s rapid COVID-19 PCR test

Pharma Times

PCR-based test has a sample collection to result time of 25 minutes

49
article thumbnail

Welsh startup Antiverse raises $2m for antibody discovery toolkit

pharmaphorum

New biotech Antiverse has raised seed funding of £1.4 million ($2 million) to develop its artificial intelligence-based platform for discovering therapeutic antibodies. The Cardiff, Wales startup is combining machine learning and phage display techniques to model antibody-antigen binding and says it can cut the time it takes to develop a drug candidate.

101
101
article thumbnail

Lymecycline for ACNE: Questions & Answers

Druggist

Lymecycline is one of the most commonly used oral antibiotics in the treatment of acne. I previously reviewed the use of different antibiotics, including lymecycline for acne. In today’s post, I will focus solely on the use of lymecycline in the treatment of acne. Summary of the post: What is Lymecycline? The legal classification of lymecycline.

59